L : , , L : Sport Store : , , L : , GoodLooker
Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Fluvoxamine Maleate [who-dd] 63
Laboratory experiments with fibroblasts have suggested that AHK-Cu may contribute to processes involved in collagen formation
doi: 10.1128/jb.128.1.192-201.1976 120 HellerJ
[PubMed: 14668333] 789
Several new therapeutic approaches aimed at slowing the progression of PD are considered disease-modifying treatments and include anti-inflammatory agents (selnoflast, azatriopine), antioxidants, agents that stimulate mitochondrial function, agents that increase glucocerebrosidase activity (ambroxol), agents that activate the glucagon-like peptide-1 receptor (exenatide, lixisenatide, Peptron), agents that block specific kinase activity (SPARCs K0706, Inhibikases IKT148009, and Il-Yangs radotinib), agents that reduce or inhibit LRRK2 activity (BIIB122), drugs that target GI tract activity (rifaximin), and molecules that prevent -syn aggregation or disaggregation of existing complexes (prasinezumab, memantine, buntanetap)
US$ 29.31
US$ 27.39
US$ 27.97
US$ 29.31
US$ 24.63
US$ 27.26
US$ 20.41